Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Oct 14;13(20):6119.
doi: 10.3390/jcm13206119.

Aggressive Types of Malignant Thyroid Neoplasms

Affiliations
Review

Aggressive Types of Malignant Thyroid Neoplasms

Maria Boudina et al. J Clin Med. .

Abstract

Differentiated thyroid cancer (DTC) includes many subtypes, which demonstrate favorable to aggressive behavior. During the past decades, efforts have been made to describe aggressive thyroid cancers. Within DTC, aggressive variants constitute rare entities with unique histopathological features and compromised survival, as local and distant metastatic disease is frequent. In recent years, the distinct category of poorly differentiated thyroid cancer was introduced in 2004 and the type of differentiated high-grade thyroid carcinoma was recently added in the 2022 WHO classification of thyroid neoplasms. Finally, anaplastic thyroid cancer exhibits a rapid, resistant to therapy, progression and confers the shortest survival. In this review, we will present the characteristics of these thyroid cancer types and also discuss the treatment, management, and follow-up of these difficult cases. Emphasis was given to recent bibliography of the last decade.

Keywords: anaplastic thyroid cancer 4; differentiated 1; differentiated high-grade 3; poorly differentiated 2.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Classification of aggressive types of thyroid cancer.

References

    1. Coca-Pelaz A., Shah J.P., Hernandez-Prera J.C., Ghossein R.A., Rodrigo J.P., Hartl D.M., Olsen K.D., Shaha A.R., Zafereo M., Suarez C., et al. Papillary Thyroid Cancer-Aggressive Variants and Impact on Management: A Narrative Review. Adv. Ther. 2020;37:3112–3128. doi: 10.1007/s12325-020-01391-1. - DOI - PMC - PubMed
    1. Pizzimenti C., Fiorentino V., Ieni A., Martini M., Tuccari G., Lentini M., Fadda G. Aggressive variants of follicular cell-derived thyroid carcinoma: An overview. Endocrine. 2022;78:1–12. doi: 10.1007/s12020-022-03146-0. - DOI - PubMed
    1. Xu B., Viswanathan K., Zhang L., Edmund L.N., Ganly O., Tuttle R.M., Lubin D., Ghossein R.A. The solid variant of papillary thyroid carcinoma: A multi-institutional retrospective study. Histopathology. 2022;81:171–182. doi: 10.1111/his.14668. - DOI - PubMed
    1. Juhlin C., Mete O., Baloch W.Z. The 2022 WHO classification of thyroid tumors: Novel concepts in nomenclature and grading. Endocr. Relat. Cancer. 2022;30:e220293. - PubMed
    1. Basolo F., Macerola E., Poma A.M., Torregrossa L. The 5th edition of WHO classification of tumors of endocrine organs: Changes in the diagnosis of follicular-derived thyroid carcinoma. Endocrine. 2023;80:470–476. doi: 10.1007/s12020-023-03336-4. - DOI - PMC - PubMed

LinkOut - more resources